Morning Overview on MSN
New research links cancer therapy and synthetic biology in a major leap
Cancer therapy and synthetic biology are converging around a shared problem that has long frustrated oncologists and ...
Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...
The Brighterside of News on MSN
New study provides a key breakthrough in cancer therapy and synthetic biology
Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.
The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.
Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...
In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread. MIAMI, FLORIDA / ACCESS ...
Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...
Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...
An Arizona patient with synovial sarcoma has received a new immune cell therapy. Officials at HonorHealth Research Institute ...
Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...
A blood cancer diagnosis comes with a lot of new information and confusion ranging from blood tests and medical terminology to healthcare provider conversations and treatment considerations. Here’s ...
Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results